Titre : Vibrio

Vibrio : Questions médicales fréquentes

Termes MeSH sélectionnés :

Trabeculectomy

Questions fréquentes et termes MeSH associés

Diagnostic 5

#1

Comment diagnostiquer une infection à Vibrio ?

Le diagnostic repose sur des cultures bactériennes à partir d'échantillons de selles.
Vibrio Infections bactériennes
#2

Quels tests sont utilisés pour identifier Vibrio ?

Des tests de culture et des tests biochimiques spécifiques sont utilisés.
Tests de laboratoire Vibrio
#3

Les tests sérologiques sont-ils utiles ?

Les tests sérologiques ne sont généralement pas utilisés pour Vibrio.
Tests sérologiques Vibrio
#4

Peut-on diagnostiquer Vibrio par PCR ?

Oui, la PCR peut être utilisée pour détecter l'ADN de Vibrio dans les échantillons.
PCR Vibrio
#5

Quels symptômes orientent vers un diagnostic de Vibrio ?

Des symptômes gastro-intestinaux comme la diarrhée aiguë peuvent indiquer une infection.
Diarrhée Vibrio

Symptômes 5

#1

Quels sont les symptômes d'une infection à Vibrio ?

Les symptômes incluent diarrhée, vomissements, douleurs abdominales et fièvre.
Symptômes Vibrio
#2

La diarrhée est-elle toujours présente ?

Non, la diarrhée est fréquente mais pas systématique dans les infections à Vibrio.
Diarrhée Vibrio
#3

Les infections à Vibrio causent-elles de la fièvre ?

Oui, la fièvre peut accompagner les infections à Vibrio, mais ce n'est pas toujours le cas.
Fièvre Vibrio
#4

Y a-t-il des symptômes graves associés ?

Des symptômes graves peuvent inclure déshydratation et choc septique dans les cas sévères.
Choc septique Vibrio
#5

Les symptômes apparaissent-ils rapidement ?

Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures suivant l'infection.
Infection Vibrio

Prévention 5

#1

Comment prévenir les infections à Vibrio ?

Évitez de consommer des fruits de mer crus ou mal cuits et lavez-vous les mains.
Prévention Vibrio
#2

Le lavage des mains est-il important ?

Oui, le lavage des mains réduit le risque d'infection par Vibrio et d'autres pathogènes.
Hygiène Vibrio
#3

Les vaccinations existent-elles contre Vibrio ?

Actuellement, il n'existe pas de vaccin efficace contre les infections à Vibrio.
Vaccins Vibrio
#4

Faut-il éviter certains aliments ?

Oui, évitez les fruits de mer crus, surtout en période de chaleur ou d'épidémies.
Alimentation Vibrio
#5

Les voyages augmentent-ils le risque d'infection ?

Oui, voyager dans des zones où Vibrio est endémique augmente le risque d'infection.
Voyages Vibrio

Traitements 5

#1

Quel est le traitement principal pour Vibrio ?

Le traitement principal est la réhydratation, souvent accompagnée d'antibiotiques si nécessaire.
Traitement Vibrio
#2

Quels antibiotiques sont efficaces contre Vibrio ?

Des antibiotiques comme la doxycycline et l'azithromycine sont souvent utilisés.
Antibiotiques Vibrio
#3

La réhydratation est-elle toujours nécessaire ?

Oui, la réhydratation est cruciale, surtout en cas de diarrhée sévère.
Réhydratation Vibrio
#4

Les traitements sont-ils différents selon le type de Vibrio ?

Oui, le traitement peut varier selon le type de Vibrio et la gravité de l'infection.
Types de Vibrio Traitement
#5

Les probiotiques aident-ils dans le traitement ?

Les probiotiques peuvent aider à restaurer la flore intestinale, mais ne remplacent pas le traitement.
Probiotiques Vibrio

Complications 5

#1

Quelles complications peuvent survenir avec Vibrio ?

Les complications incluent la déshydratation sévère, le choc septique et l'insuffisance rénale.
Complications Vibrio
#2

La déshydratation est-elle une complication fréquente ?

Oui, la déshydratation est une complication courante, surtout en cas de diarrhée sévère.
Déshydratation Vibrio
#3

Les infections à Vibrio peuvent-elles être mortelles ?

Oui, dans les cas graves, les infections à Vibrio peuvent être mortelles sans traitement rapide.
Mortalité Vibrio
#4

Y a-t-il des risques pour les personnes immunodéprimées ?

Oui, les personnes immunodéprimées sont à risque accru de complications graves.
Immunodépression Vibrio
#5

Les infections cutanées sont-elles possibles ?

Oui, Vibrio peut causer des infections cutanées, surtout après des blessures en milieu aquatique.
Infections cutanées Vibrio

Facteurs de risque 5

#1

Quels sont les principaux facteurs de risque pour Vibrio ?

Les principaux facteurs incluent la consommation de fruits de mer crus et l'immunodépression.
Facteurs de risque Vibrio
#2

Les personnes âgées sont-elles plus à risque ?

Oui, les personnes âgées ont un risque accru de complications graves liées à Vibrio.
Personnes âgées Vibrio
#3

Le diabète augmente-t-il le risque d'infection ?

Oui, le diabète peut augmenter le risque d'infections graves à Vibrio.
Diabète Vibrio
#4

Les personnes vivant près de l'eau sont-elles plus exposées ?

Oui, elles peuvent être plus exposées aux infections à Vibrio, surtout en été.
Exposition Vibrio
#5

Les voyages dans des zones endémiques sont-ils risqués ?

Oui, voyager dans des zones où Vibrio est courant augmente le risque d'infection.
Voyages Vibrio
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Vibrio : Questions médicales les plus fréquentes", "headline": "Vibrio : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Vibrio : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-05-05", "dateModified": "2025-04-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Vibrio" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Vibrionaceae", "url": "https://questionsmedicales.fr/mesh/D014737", "about": { "@type": "MedicalCondition", "name": "Vibrionaceae", "code": { "@type": "MedicalCode", "code": "D014737", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830" } } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vibrio alginolyticus", "alternateName": "Vibrio alginolyticus", "url": "https://questionsmedicales.fr/mesh/D044149", "about": { "@type": "MedicalCondition", "name": "Vibrio alginolyticus", "code": { "@type": "MedicalCode", "code": "D044149", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.030" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae", "alternateName": "Vibrio cholerae", "url": "https://questionsmedicales.fr/mesh/D014734", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae", "code": { "@type": "MedicalCode", "code": "D014734", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100" } }, "hasPart": [ { "@type": "MedicalWebPage", "name": "Vibrio cholerae non-O1", "alternateName": "Vibrio cholerae non-O1", "url": "https://questionsmedicales.fr/mesh/D044163", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae non-O1", "code": { "@type": "MedicalCode", "code": "D044163", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.075" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae O1", "alternateName": "Vibrio cholerae O1", "url": "https://questionsmedicales.fr/mesh/D041241", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae O1", "code": { "@type": "MedicalCode", "code": "D041241", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.151" } } }, { "@type": "MedicalWebPage", "name": "Vibrio cholerae O139", "alternateName": "Vibrio cholerae O139", "url": "https://questionsmedicales.fr/mesh/D041242", "about": { "@type": "MedicalCondition", "name": "Vibrio cholerae O139", "code": { "@type": "MedicalCode", "code": "D041242", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.100.200" } } } ] }, { "@type": "MedicalWebPage", "name": "Vibrio mimicus", "alternateName": "Vibrio mimicus", "url": "https://questionsmedicales.fr/mesh/D044164", "about": { "@type": "MedicalCondition", "name": "Vibrio mimicus", "code": { "@type": "MedicalCode", "code": "D044164", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.500" } } }, { "@type": "MedicalWebPage", "name": "Vibrio parahaemolyticus", "alternateName": "Vibrio parahaemolyticus", "url": "https://questionsmedicales.fr/mesh/D014736", "about": { "@type": "MedicalCondition", "name": "Vibrio parahaemolyticus", "code": { "@type": "MedicalCode", "code": "D014736", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.590" } } }, { "@type": "MedicalWebPage", "name": "Vibrio vulnificus", "alternateName": "Vibrio vulnificus", "url": "https://questionsmedicales.fr/mesh/D041261", "about": { "@type": "MedicalCondition", "name": "Vibrio vulnificus", "code": { "@type": "MedicalCode", "code": "D041261", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "B03.660.250.830.830.900" } } } ], "about": { "@type": "MedicalCondition", "name": "Vibrio", "alternateName": "Vibrio", "code": { "@type": "MedicalCode", "code": "D014733", "codingSystem": "MeSH" } }, "author": [ { "@type": "Person", "name": "Jaime Martinez-Urtaza", "url": "https://questionsmedicales.fr/author/Jaime%20Martinez-Urtaza", "affiliation": { "@type": "Organization", "name": "Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain." } }, { "@type": "Person", "name": "Jessica L Jones", "url": "https://questionsmedicales.fr/author/Jessica%20L%20Jones", "affiliation": { "@type": "Organization", "name": "U.S. Food and Drug Administration Gulf Coast Seafood Laboratory 1 Iberville Drive UNITED STATES Dauphin Island AL 36528 2514068136." } }, { "@type": "Person", "name": "William C Walton", "url": "https://questionsmedicales.fr/author/William%20C%20Walton", "affiliation": { "@type": "Organization", "name": "2Auburn University Shellfish Laboratory, School of Fisheries, Aquaculture, and Aquatic Sciences, Auburn University, 150 Agassiz Street, Dauphin Island, AL 36528, USA." } }, { "@type": "Person", "name": "Julia C van Kessel", "url": "https://questionsmedicales.fr/author/Julia%20C%20van%20Kessel", "affiliation": { "@type": "Organization", "name": "Biology Department, Indiana University, Bloomington, Indiana, USA jcvk@indiana.edu." } }, { "@type": "Person", "name": "Blake Ushijima", "url": "https://questionsmedicales.fr/author/Blake%20Ushijima", "affiliation": { "@type": "Organization", "name": "Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America." } } ], "citation": [ { "@type": "ScholarlyArticle", "name": "[Trabeculectomy with mitomycin C and Ologen® implant in comparison to classical trabeculectomy].", "datePublished": "2022-07-13", "url": "https://questionsmedicales.fr/article/35925352", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00347-022-01686-4" } }, { "@type": "ScholarlyArticle", "name": "Device-modified trabeculectomy for glaucoma.", "datePublished": "2023-03-13", "url": "https://questionsmedicales.fr/article/36912740", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1002/14651858.CD010472.pub3" } }, { "@type": "ScholarlyArticle", "name": "Comparison of Repeat Trabeculectomy Versus Ahmed Valve Implantation After Initial Failed Trabeculectomy Surgery.", "datePublished": "2023-05-26", "url": "https://questionsmedicales.fr/article/37311016", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002240" } }, { "@type": "ScholarlyArticle", "name": "[Why trabeculectomy is better than its reputation].", "datePublished": "2022-09-08", "url": "https://questionsmedicales.fr/article/36074170", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00347-022-01720-5" } }, { "@type": "ScholarlyArticle", "name": "Malignant Glaucoma Post Gonioscopy-Assisted Transluminal Trabeculectomy.", "datePublished": "2023-04-01", "url": "https://questionsmedicales.fr/article/37079497", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1097/IJG.0000000000002226" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "Bactéries", "item": "https://questionsmedicales.fr/mesh/D001419" }, { "@type": "ListItem", "position": 3, "name": "Proteobacteria", "item": "https://questionsmedicales.fr/mesh/D020560" }, { "@type": "ListItem", "position": 4, "name": "Gammaproteobacteria", "item": "https://questionsmedicales.fr/mesh/D020563" }, { "@type": "ListItem", "position": 5, "name": "Vibrionaceae", "item": "https://questionsmedicales.fr/mesh/D014737" }, { "@type": "ListItem", "position": 6, "name": "Vibrio", "item": "https://questionsmedicales.fr/mesh/D014733" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Vibrio - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Vibrio", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-12", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Vibrio", "description": "Comment diagnostiquer une infection à Vibrio ?\nQuels tests sont utilisés pour identifier Vibrio ?\nLes tests sérologiques sont-ils utiles ?\nPeut-on diagnostiquer Vibrio par PCR ?\nQuels symptômes orientent vers un diagnostic de Vibrio ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Trabeculectomy#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Vibrio", "description": "Quels sont les symptômes d'une infection à Vibrio ?\nLa diarrhée est-elle toujours présente ?\nLes infections à Vibrio causent-elles de la fièvre ?\nY a-t-il des symptômes graves associés ?\nLes symptômes apparaissent-ils rapidement ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Trabeculectomy#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Vibrio", "description": "Comment prévenir les infections à Vibrio ?\nLe lavage des mains est-il important ?\nLes vaccinations existent-elles contre Vibrio ?\nFaut-il éviter certains aliments ?\nLes voyages augmentent-ils le risque d'infection ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Trabeculectomy#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Vibrio", "description": "Quel est le traitement principal pour Vibrio ?\nQuels antibiotiques sont efficaces contre Vibrio ?\nLa réhydratation est-elle toujours nécessaire ?\nLes traitements sont-ils différents selon le type de Vibrio ?\nLes probiotiques aident-ils dans le traitement ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Trabeculectomy#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Vibrio", "description": "Quelles complications peuvent survenir avec Vibrio ?\nLa déshydratation est-elle une complication fréquente ?\nLes infections à Vibrio peuvent-elles être mortelles ?\nY a-t-il des risques pour les personnes immunodéprimées ?\nLes infections cutanées sont-elles possibles ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Trabeculectomy#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Vibrio", "description": "Quels sont les principaux facteurs de risque pour Vibrio ?\nLes personnes âgées sont-elles plus à risque ?\nLe diabète augmente-t-il le risque d'infection ?\nLes personnes vivant près de l'eau sont-elles plus exposées ?\nLes voyages dans des zones endémiques sont-ils risqués ?", "url": "https://questionsmedicales.fr/mesh/D014733?mesh_terms=Trabeculectomy#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer une infection à Vibrio ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur des cultures bactériennes à partir d'échantillons de selles." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour identifier Vibrio ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de culture et des tests biochimiques spécifiques sont utilisés." } }, { "@type": "Question", "name": "Les tests sérologiques sont-ils utiles ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Les tests sérologiques ne sont généralement pas utilisés pour Vibrio." } }, { "@type": "Question", "name": "Peut-on diagnostiquer Vibrio par PCR ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la PCR peut être utilisée pour détecter l'ADN de Vibrio dans les échantillons." } }, { "@type": "Question", "name": "Quels symptômes orientent vers un diagnostic de Vibrio ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes gastro-intestinaux comme la diarrhée aiguë peuvent indiquer une infection." } }, { "@type": "Question", "name": "Quels sont les symptômes d'une infection à Vibrio ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes incluent diarrhée, vomissements, douleurs abdominales et fièvre." } }, { "@type": "Question", "name": "La diarrhée est-elle toujours présente ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Non, la diarrhée est fréquente mais pas systématique dans les infections à Vibrio." } }, { "@type": "Question", "name": "Les infections à Vibrio causent-elles de la fièvre ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la fièvre peut accompagner les infections à Vibrio, mais ce n'est pas toujours le cas." } }, { "@type": "Question", "name": "Y a-t-il des symptômes graves associés ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes graves peuvent inclure déshydratation et choc septique dans les cas sévères." } }, { "@type": "Question", "name": "Les symptômes apparaissent-ils rapidement ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent apparaître rapidement, souvent dans les 24 heures suivant l'infection." } }, { "@type": "Question", "name": "Comment prévenir les infections à Vibrio ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Évitez de consommer des fruits de mer crus ou mal cuits et lavez-vous les mains." } }, { "@type": "Question", "name": "Le lavage des mains est-il important ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le lavage des mains réduit le risque d'infection par Vibrio et d'autres pathogènes." } }, { "@type": "Question", "name": "Les vaccinations existent-elles contre Vibrio ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Actuellement, il n'existe pas de vaccin efficace contre les infections à Vibrio." } }, { "@type": "Question", "name": "Faut-il éviter certains aliments ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, évitez les fruits de mer crus, surtout en période de chaleur ou d'épidémies." } }, { "@type": "Question", "name": "Les voyages augmentent-ils le risque d'infection ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où Vibrio est endémique augmente le risque d'infection." } }, { "@type": "Question", "name": "Quel est le traitement principal pour Vibrio ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Le traitement principal est la réhydratation, souvent accompagnée d'antibiotiques si nécessaire." } }, { "@type": "Question", "name": "Quels antibiotiques sont efficaces contre Vibrio ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Des antibiotiques comme la doxycycline et l'azithromycine sont souvent utilisés." } }, { "@type": "Question", "name": "La réhydratation est-elle toujours nécessaire ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la réhydratation est cruciale, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les traitements sont-ils différents selon le type de Vibrio ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le traitement peut varier selon le type de Vibrio et la gravité de l'infection." } }, { "@type": "Question", "name": "Les probiotiques aident-ils dans le traitement ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les probiotiques peuvent aider à restaurer la flore intestinale, mais ne remplacent pas le traitement." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec Vibrio ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la déshydratation sévère, le choc septique et l'insuffisance rénale." } }, { "@type": "Question", "name": "La déshydratation est-elle une complication fréquente ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la déshydratation est une complication courante, surtout en cas de diarrhée sévère." } }, { "@type": "Question", "name": "Les infections à Vibrio peuvent-elles être mortelles ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, dans les cas graves, les infections à Vibrio peuvent être mortelles sans traitement rapide." } }, { "@type": "Question", "name": "Y a-t-il des risques pour les personnes immunodéprimées ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes immunodéprimées sont à risque accru de complications graves." } }, { "@type": "Question", "name": "Les infections cutanées sont-elles possibles ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, Vibrio peut causer des infections cutanées, surtout après des blessures en milieu aquatique." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque pour Vibrio ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les principaux facteurs incluent la consommation de fruits de mer crus et l'immunodépression." } }, { "@type": "Question", "name": "Les personnes âgées sont-elles plus à risque ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les personnes âgées ont un risque accru de complications graves liées à Vibrio." } }, { "@type": "Question", "name": "Le diabète augmente-t-il le risque d'infection ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le diabète peut augmenter le risque d'infections graves à Vibrio." } }, { "@type": "Question", "name": "Les personnes vivant près de l'eau sont-elles plus exposées ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, elles peuvent être plus exposées aux infections à Vibrio, surtout en été." } }, { "@type": "Question", "name": "Les voyages dans des zones endémiques sont-ils risqués ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, voyager dans des zones où Vibrio est courant augmente le risque d'infection." } } ] } ] }
Dr Olivier Menir

Contenu validé par Dr Olivier Menir

Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale


Validation scientifique effectuée le 30/04/2025

Contenu vérifié selon les dernières recommandations médicales

Auteurs principaux

Jaime Martinez-Urtaza

4 publications dans cette catégorie

Affiliations :
  • Department of Genetics and Microbiology, Universitat Autònoma de Barcelona, Barcelona, Spain.
Publications dans "Vibrio" :

Jessica L Jones

3 publications dans cette catégorie

Affiliations :
  • U.S. Food and Drug Administration Gulf Coast Seafood Laboratory 1 Iberville Drive UNITED STATES Dauphin Island AL 36528 2514068136.

William C Walton

3 publications dans cette catégorie

Affiliations :
  • 2Auburn University Shellfish Laboratory, School of Fisheries, Aquaculture, and Aquatic Sciences, Auburn University, 150 Agassiz Street, Dauphin Island, AL 36528, USA.

Julia C van Kessel

3 publications dans cette catégorie

Affiliations :
  • Biology Department, Indiana University, Bloomington, Indiana, USA jcvk@indiana.edu.
Publications dans "Vibrio" :

Blake Ushijima

2 publications dans cette catégorie

Affiliations :
  • Carlson College of Veterinary Medicine, Oregon State University, Corvallis, OR, United States of America.

Fazlurrahman Khan

2 publications dans cette catégorie

Affiliations :
  • Research Center for Marine Integrated Bionics Technology, Pukyong National University, Busan, 48513, South Korea.

Young-Mog Kim

2 publications dans cette catégorie

Affiliations :
  • Department of Food Science and Technology, Pukyong National University, Busan, 48513, South Korea. ymkim@pknu.ac.kr.
  • Research Center for Marine Integrated Bionics Technology, Pukyong National University, Busan, 48513, South Korea. ymkim@pknu.ac.kr.

Heidi A Butz

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA.
Publications dans "Vibrio" :

Alexandra R Mey

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA.
Publications dans "Vibrio" :

Ashley L Ciosek

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA.
Publications dans "Vibrio" :

Bryan W Davies

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA.

Shelley M Payne

2 publications dans cette catégorie

Affiliations :
  • Department of Molecular Biosciences and LaMontagne Center for Infectious Diseases, The University of Texas at Austin, Austin, Texas, USA payne@utexas.edu.
Publications dans "Vibrio" :

Craig Baker-Austin

2 publications dans cette catégorie

Affiliations :
  • International Centre of Excellence for Seafood Safety, Centre for Environment, Fisheries and Aquaculture Science, Weymouth, UK. Electronic address: craig.baker-austin@cefas.co.uk.
Publications dans "Vibrio" :

Joaquin Trinanes

2 publications dans cette catégorie

Affiliations :
  • Laboratory of Systems, Technological Research Institute, Universidad de Santiago de Compostela, Santiago de Compostela, Spain.
Publications dans "Vibrio" :

Shigeaki Matsuda

2 publications dans cette catégorie

Affiliations :
  • Department of Bacterial Infections, Research Institute for Microbial Diseases, Osaka University.
Publications dans "Vibrio" :

Chao Yang

2 publications dans cette catégorie

Affiliations :
  • State Key Laboratory of Pathogen and Biosecurity, Beijing Institute of Microbiology and Epidemiology, Beijing, 100071, China.
Publications dans "Vibrio" :

Lin Yan

2 publications dans cette catégorie

Affiliations :
  • National Center for Food Safety Risk Assessment, Beijing, 100022, China.
Publications dans "Vibrio" :

Salvador Almagro-Moreno

2 publications dans cette catégorie

Affiliations :
  • Burnett School of Biomedical Sciences, University of Central Florida, Orlando, FL, USA. samoreno@ucf.edu.
  • National Center for Integrated Coastal Research, University of Central Florida, Orlando, FL, USA. samoreno@ucf.edu.
Publications dans "Vibrio" :

Orr H Shapiro

2 publications dans cette catégorie

Affiliations :
  • Department of Plant and Environmental Sciences, Weizmann Institute of Science, Rehovot, Israel. orr@agri.gov.il.
  • Department of Food Quality and Safety, Agricultural Research Organization, Volcani Center, Rishon LeZion, Israel. orr@agri.gov.il.
Publications dans "Vibrio" :

Victoria L Pruente

2 publications dans cette catégorie

Affiliations :
  • U.S. Food and Drug Administration, Division of Seafood Science and Technology, Gulf Coast Seafood Laboratory, 1 Iberville Drive, Dauphin Island, AL 36528, USA; Auburn University Shellfish Laboratory, School of Fisheries, Aquaculture, and Aquatic Sciences, Auburn University, 150 Agassiz Street, Dauphin Island, AL 36528, USA. Electronic address: vlp0006@auburn.edu.

Sources (332 au total)

[Trabeculectomy with mitomycin C and Ologen® implant in comparison to classical trabeculectomy].

Trabeculectomy (TE) with mitomycin C (MMC) is considered the gold standard in glaucoma surgery. A new modification is the use of an Ologen® implant (AEON Astron Europe B.V., Leiden, Netherlands) durin... On 70 eyes Ologen® was applied during surgery (group 2), whereas 98 eyes were operated on without the implant (group 1). Both surgical procedures were compared regarding the efficiency of lowering the... In group 1 the IOP was lowered from 28.0 mmHg (95% confidence interval, CI 26.6-29.4 mmHg) to 16.0 mmHg (14.0-18.1) after 24 months. In group 2, the pressure dropped from 28.5 mmHg (26.8-30.1) to 14.3... Both procedures significantly lower the IOP and the number of glaucoma medications. For our cases, TE with Ologen® and MMC is considered to be superior to TE with MMC regarding the lower rates of foll...

Device-modified trabeculectomy for glaucoma.

Glaucoma is an optic neuropathy that leads to visual field defects and vision loss. It is the second leading cause of irreversible blindness in the world. Treatment for glaucoma aims to reduce intraoc... To evaluate the benefits and harms of different devices as adjuncts to trabeculectomy on IOP control in eyes with glaucoma compared to standard trabeculectomy.... We used standard, extensive Cochrane search methods. The latest search was August 2021.... We included randomized controlled trials in participants with glaucoma comparing device-modified trabeculectomy techniques with standard trabeculectomy. We included studies that used antimetabolites i... We used standard Cochrane methods. Our primary outcomes were 1. change in IOP and 2. mean postoperative IOP at one year. Our secondary outcomes were 3. mean change in IOP from baseline, 4. mean postop... Eight studies met our inclusion criteria, of which seven were full-length journal articles and one was a conference abstract. The eight studies included 961 participants with glaucoma, and compared tw... Use of an Ex-PRESS plus trabeculectomy may produce greater IOP reduction at one-year follow-up than standard trabeculectomy; however, due to potential biases and imprecision in effect estimates, the c...

Comparison of Repeat Trabeculectomy Versus Ahmed Valve Implantation After Initial Failed Trabeculectomy Surgery.

Repeat trabeculectomy is associated with similar postoperative intraocular pressure (IOP), a lower complication rate, and a lower need for medications when compared with Ahmed valve implantation (AVI)... The goal of this study was to compare the efficacy of repeat trabeculectomies and AVI after an initial failed trabeculectomy.... All studies that investigated the postoperative success of patients who underwent AVI or repeat trabeculectomy with mitomycin- C after a prior failed trabeculectomy with mitomycin- C found in PubMed, ... The literature search yielded 1305 studies, and 14 studies were included in the final analysis. Mean IOP was not significantly different between the two groups preoperatively and then after 1, 2, and ... Repeat trabeculectomy with mitomycin- C and AVI may both be considered after failed primary trabeculectomy. However, our analysis suggests that repeat trabeculectomy may be the preferred method as it ...

[Why trabeculectomy is better than its reputation].

Trabeculectomy (TE) remains one of the most frequently performed glaucoma procedures. This surgery enables sufficient reduction of intraocular pressure (IOP) and freedom from using eye drops; however,... This review presents the value of TE compared to other forms of filtering and nonfiltering glaucoma surgery.... The use of TE is still the most effective method for lowering IOP and in comparison to other forms of glaucoma surgery in most cases enables freedom from eye drops with a subsequent high quality of li...

Long-Term Safety and Outcomes of β-radiation for Trabeculectomy.

β-radiation is a neglected antiscarring therapy with past concerns for safety. This report found it safe and efficacious when used as an adjuvant to trabeculectomy surgery in 101 people (135 eyes) ove... β-radiation has been used as an adjunct to prevent scarring in trabeculectomy surgery for many decades. Safety concerns were raised with the use of high doses on the bare sclera. Moorfields Eye Hospit... Cases undertaken between August 1992 and August 1996 were reviewed. Those with records available for postoperative review of more than 5 years were included. Failure (reintervention/>21 mm Hg on 2 suc... In total, 292 operations using β-radiation were recorded and 101 people (135 eyes) with trabeculectomy surgery and postoperative follow-up for over 4.5 years were included. The median follow-up period... In glaucoma patients at risk of scarring and failure after trabeculectomy, as an antiscarring adjuvant, a 750 cGY dose of β-radiation was found to be safe and efficacious in the long term....

Effect of trabeculectomy on the rate of progression of visual field damage.

This study quantifies the effect of trabeculectomy on the rate of progression (RoP) of visual field (VF) damage utilising pre- and post-operative visual function as the outcome instead of surrogate ou... Clinical and VF data from 199 sequential patients who underwent trabeculectomy between 2015 and 2016 were extracted from the network of sites of Moorfields Eye Hospital NHS Foundation Trust. Of these,... We analysed 10 [9,12] VFs per subject (Median [Interquartile Range]). At surgery, the age was 67 [57, 72] years, mean deviation was -10.84 [-14.7, -5.6] dB and the IOP was 18 [15, 20] mmHg. One year a... Trabeculectomy leads to a significant reduction in the RoP of VF loss postoperatively....

Anterior chamber proliferative membrane interception (AC-PMI)-enhanced trabeculectomy versus trabeculectomy for treating neovascular glaucoma: protocol for a randomized controlled trial.

Neovascular glaucoma (NVG) is an irreversible blinding eye disease worldwide and is classified as one of the refractory glaucoma conditions, severely impacting visual function and vision. Unfortunatel... AC-PMI enhanced trabeculectomy versus trabeculectomy for the treatment of NVG is a single-center, prospective, double-arms, and randomized controlled trial of superior efficacy, which will involve 100... This is an efficacy study of a novel surgical approach for treating neovascular glaucoma. Building upon conventional filtering surgeries, this approach introduces an additional step involving the inte... ChiCTR ChiCTR2200055138. Registered on 01 January 2022. https://www.chictr.org.cn/showproj.html?proj=145255....

Comparison of Trabeculectomy Outcomes Performed by Residents in Training and Ophthalmologists.

Resident-performed trabeculectomies present higher intraocular pressure and lower complete success rate at 1 year.... To compare the 1-year outcomes of ab externo trabeculectomy between residents in training and staff ophthalmologists.... This retrospective study included all consecutive eyes submitted to ab externo trabeculectomy between January 2015 to June 2020. A 1-year complete success rate was considered using all the following c... One hundred and ten eyes from 99 patients were included. Thirty percent (n=33) of the trabeculectomies were performed by residents. There were no significant preoperative differences between groups, a... Resident-performed trabeculectomies present significantly higher postoperative IOP levels and a lower complete success rate when compared with staff ophthalmologists. It is, therefore, fundamental to ...

Failed Ahmed glaucoma valves: trabeculectomy versus repeat shunt surgery.

To investigate the outcomes of trabeculectomy (TRAB) versus repeat Ahmed glaucoma valve (re-AGV) implantation in eyes with Ahmed glaucoma valve (AGV) failure.... This quasi-experimental study includes patients with failed AGV implants requiring additional surgical intervention between 2018 and 2022. Patients in the TRAB group underwent a fornix-based procedure... Forty-eight eyes of 48 patients were operated and reported herein, consisting of 22 eyes of 22 patients undergoing TRAB and 26 eyes of 26 subjects undergoing re-AGV. No significant difference was obse... Trabeculectomy can be considered a safe and effective surgical option in eyes with failed AGV leading to significantly lower IOP levels and more favorable success rates than re-AGV in selected patient...